Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -7009.96x is 322% below its 5-year average of -1661.75x, near the low end of its 5-year range (-7009.96x–-6.68x).
As of the fiscal period ended Saturday, July 31, 2021. 6.12% below its 12-month average of -6605.85x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2021 (2021-07-31): -7009.96x.
INTEREST COVERAGE RATIO
-7009.96x
INTEREST COVERAGE RATIO AVG TTM
-6605.85x
INTEREST COVERAGE RATIO AVG 3Y
-6605.85x
INTEREST COVERAGE RATIO AVG 5Y
-1661.75x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-6.12%
CURRENT VS 3Y AVG
-6.12%
CURRENT VS 5Y AVG
-321.84%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-109860.18%
vs the sector median at left
Anixa Biosciences, Inc.
Market Cap
$104.96M
Interest Coverage Ratio
-7009.96x
TTM Avg
-6605.85x
3Y Avg
-6605.85x
5Y Avg
-1661.75x
Market Cap
$105.33M
Interest Coverage Ratio
-1.82x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.18M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$103.43M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$103.06M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$106.50M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$107.00M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$102.57M
Interest Coverage Ratio
N/A
TTM Avg
2.91x
3Y Avg
2.91x
5Y Avg
2.91x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anixa Biosciences, Inc. (ANIX) | $104.96M | -7009.96x | -6605.85x | -6605.85x | -1661.75x |
| Definitive Healthcare Corp. (DH)vs › | $105.33M | -1.82x | N/A | N/A | N/A |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.18M | N/A | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.43M | N/A | N/A | N/A | N/A |
| OnKure Therapeutics, Inc. (OKUR)vs › | $103.06M | N/A | N/A | N/A | N/A |
| Vivani Medical, Inc. (VANI)vs › | $106.50M | N/A | N/A | N/A | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.00M | N/A | N/A | N/A | N/A |
| The Joint Corp. (JYNT)vs › | $102.57M | N/A | 2.91x | 2.91x | 2.91x |
| Immunic, Inc. (IMUX)vs › | $107.47M | N/A | N/A | N/A | N/A |
| Outlook Therapeutics, Inc. (OTLK)vs › | $108.20M | -236.86x | N/A | N/A | N/A |
Interest Coverage
-7010.0x
Debt/Equity
0.01
Current Ratio
8.54
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-07-31 | -7009.96x |
| 2021-04-30 | -6201.74x |
| 2017-10-31 | -30.08x |
| 2017-07-31 | -24.15x |
| 2017-04-30 | -6.90x |
| 2017-01-31 | -7.14x |
| 2016-10-31 | -6.68x |
| 2016-07-31 | -7.37x |
| 2016-04-30 | -9.04x |
| 2016-01-31 | -11.88x |
| 2015-10-31 | -9.97x |
| 2015-07-31 | -12.85x |
| 2015-04-30 | -19.64x |
| 2015-01-31 | 35.32x |
| 2014-10-31 | -8.62x |
| 2014-07-31 | -0.57x |
| 2014-04-30 | -3.21x |
| 2014-01-31 | -5.19x |
| 2013-10-31 | -14.00x |
| 2013-07-31 | -17.74x |
| 2013-04-30 | -2.22x |
| 2013-01-31 | -93.39x |
| 2012-10-31 | -225.18x |
